Mutant-Allele Tumor Heterogeneity Scores Correlate With Risk of Metastases in Colon Cancer

Measures of tumor heterogeneity might be useful biomarkers for identifying patients with colon cancer who are at risk of developing metastases. This might allow for more specific, tailored follow-up and adjuvant therapies after standard surgery.